Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059075) titled 'Randomized Phase II trial Evaluating the Efficacy of ZolbEtuximab in the second-line for CLaudin18.2 Positive AdvanceD GAstric/EGJ Cancer Patients Previously Treated with Zolbetuximab and Platinum-Based Chemotherapy (ZELDA trial):Translational Biomarker Research (ZELDA-TR trial)' on Oct. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Kyushu Studygroup of Clinical Cancer
Condition:
Condition - gastric cancer and esophagogastric junction (EGJ) cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - This translational research will perform exploratory an...